These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38555718)
1. Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients. Lévesque H; Viallard JF; Houivet E; Bonnotte B; Voisin S; Le Cam-Duchez V; Maillot F; Lambert M; Liozon E; Hervier B; Fain O; Guillet B; Schmidt J; Luca LE; Ebbo M; Ferreira-Maldent N; Babuty A; Sailler L; Duffau P; Barbay V; Audia S; Benichou J; Graveleau J; Benhamou Y; Thromb Res; 2024 May; 237():79-87. PubMed ID: 38555718 [TBL] [Abstract][Full Text] [Related]
2. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report. Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A; Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903 [TBL] [Abstract][Full Text] [Related]
4. Single-dose rituximab plus glucocorticoid versus cyclophosphamide plus glucocorticoid in patients with newly diagnosed acquired hemophilia A: A multicenter, open-label, randomized noninferiority trial. Wang P; Zhou R; Xue F; Zhou H; Bai J; Wang X; Ma Y; Song Z; Chen Y; Liu X; Fu R; Sun T; Ju M; Dai X; Dong H; Yang R; Liu W; Zhang L Am J Hematol; 2024 Jan; 99(1):28-37. PubMed ID: 37851608 [TBL] [Abstract][Full Text] [Related]
5. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. Field JJ; Fenske TS; Blinder MA Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724 [TBL] [Abstract][Full Text] [Related]
6. Acquired Hemophilia A: A Retrospective Multicenter Analysis of 42 Patients. Liu Y; Ruan X; Lei P; Shang B; Zhu Z; Chen S; Wang D; Wang R; Li X; Xue F Clin Appl Thromb Hemost; 2023; 29():10760296221151165. PubMed ID: 36653966 [TBL] [Abstract][Full Text] [Related]
7. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia. Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Shaffer LG; Phillips MD Ann Intern Med; 1997 Aug; 127(3):206-9. PubMed ID: 9245226 [TBL] [Abstract][Full Text] [Related]
9. Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study. Schep SJ; van Dijk WEM; Beckers EAM; Meijer K; Coppens M; Eikenboom J; Leebeek FWG; van Vulpen LFD; Fischer KF; Schutgens REG; Am J Hematol; 2021 Jan; 96(1):51-59. PubMed ID: 32974947 [TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity, risk factor-stratified immunosuppression for acquired hemophilia A: single-center observational study. Dobbelstein C; Moschovakis GL; Tiede A Ann Hematol; 2020 Sep; 99(9):2105-2112. PubMed ID: 32621181 [TBL] [Abstract][Full Text] [Related]
11. [Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica]. Braunert L; Bruegel M; Pfrepper C; Thiery J; Niederwieser D Hamostaseologie; 2010 Nov; 30 Suppl 1():S40-3. PubMed ID: 21042682 [TBL] [Abstract][Full Text] [Related]
12. Inhibitor eradication and treatment for acquired hemophilia A. Franchini M; Focosi D Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599 [TBL] [Abstract][Full Text] [Related]
13. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A. Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303 [TBL] [Abstract][Full Text] [Related]
14. Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors. Lim MY; Nielsen B; Lee K; Kasthuri RS; Key NS; Ma AD J Thromb Haemost; 2014 Jun; 12(6):897-901. PubMed ID: 24702722 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes in the treatment of acquired hemophilia A: a 16-year single institution prospective cohort experience. Loloi J; Moroi MK; Songdej N; Al-Mondhiry HA Blood Coagul Fibrinolysis; 2020 Jan; 31(1):43-47. PubMed ID: 31789659 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of acquired hemophilia A. Tiede A Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):19-23. PubMed ID: 38066859 [TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation]. Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611 [TBL] [Abstract][Full Text] [Related]
18. Emicizumab for the treatment of acquired hemophilia A. Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881 [TBL] [Abstract][Full Text] [Related]
19. Acquired hemophilia successfully treated with oral immunosuppressive therapy. Lee JJ; Chung IJ; Park MR; Yang DH; Cho SH; Ryang DW; Kim HJ Korean J Intern Med; 2000 Jul; 15(2):135-7. PubMed ID: 10992727 [TBL] [Abstract][Full Text] [Related]
20. Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Aggarwal A; Grewal R; Green RJ; Boggio L; Green D; Weksler BB; Wiestner A; Schechter GP Haemophilia; 2005 Jan; 11(1):13-9. PubMed ID: 15660983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]